# Instituto Nacional de Oncología y Radiobiología (INOR)

Source: https://onco.cc/institutions/inor-cuba/  
OnCo record `inor-cuba` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

INOR in Havana is Cuba's national cancer hospital and coordinates the national cancer control programme; it is the clinical partner of the Center of Molecular Immunology, whose home-grown lung cancer vaccine CIMAvax-EGF and antibody nimotuzumab were tested in INOR-led trials.

## Summary

The Instituto Nacional de Oncología y Radiobiología is Cuba's national cancer hospital and research institute, under the Ministry of Public Health, providing surgical oncology, medical oncology, radiotherapy, nuclear medicine and palliative care and coordinating the national cancer control programme. It is the main clinical partner of the Center of Molecular Immunology (CIM), where Cuban biotechnology developed the EGF-targeted lung cancer vaccine CIMAvax-EGF, the anti-EGFR antibody nimotuzumab and other immunotherapies that were tested in INOR-led trials. INOR also trains oncologists for Cuba and partner countries.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: INOR Havana
- City: Havana, CU
- Type: cancer-center
- Website: https://instituciones.sld.cu/inor

## Sources

- Official website: https://instituciones.sld.cu/inor

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- targets: [EGFR](https://onco.cc/targets/egfr/)
- people: [Luis Eduardo Martín Rodríguez](https://onco.cc/people/luis-eduardo-martin-rodriguez/)

---
JSON: https://onco.cc/api/v1/entities/inor-cuba.json